AI-generated summary
The authors report that daily transcranial low-level laser irradiation for 5 days after injecting beta amyloid into rat hippocampus reduced neurodegeneration and memory impairments. They describe improvements in mitochondrial function, oxidative stress, inflammation and tau changes in the animal model. The findings come from an animal study and the abstract does not report a human outcome.
- Who or what was studied
- Adult male rats with beta amyloid injected into the hippocampal CA1 region
- Limits stated in the abstract
- The abstract reports only an animal study and does not state the number of animals or the laser wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Mild cognitive impairment, Adenosine triphosphate, Cytochrome c oxidase, Neuroinflammation, Oxidative stress, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.